Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2023 | 2 |
2024 | 1 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
Repressing HIF-1α-induced HDAC9 contributes to the synergistic effect of venetoclax and MENIN inhibitor in KMT2Ar AML.
Biomark Res. 2023 Dec 5;11(1):105. doi: 10.1186/s40364-023-00547-9.
Biomark Res. 2023.
PMID: 38053201
Free PMC article.
Gilteritinib-based combination therapy in adult relapsed/refractory FLT3-mutated acute myeloid leukaemia.
Chen N, Pan J, Zhou Y, Mao L, Lou Y, Qian J, Xu G, Wei J, Zhou D, Shou L, Huang L, Yan M, Zeng H, Fan C, Wu G, Feng W, Tong H, Jin J, Wang H.
Chen N, et al.
Br J Haematol. 2024 Mar;204(3):861-870. doi: 10.1111/bjh.19182. Epub 2023 Nov 8.
Br J Haematol. 2024.
PMID: 37939390
Item in Clipboard
Cite
Cite